Navigation Links
CredenceHealth the Preferred Solution for Clinical Surveillance in TX, OK
Date:10/4/2010

NASHVILLE, Tenn., Oct. 4 /PRNewswire/ -- CredenceHealth has been selected by the Texas Hospital Association as an endorsed solution for hospitals throughout Texas and Oklahoma. The endorsement comes following a rigorous evaluation by THA and its marketing subsidiary, HealthSHARE.  The THA-endorsed company seal of approval is given to companies delivering leading-edge products and services that increase the quality and efficiency of care, and is only granted to those companies that have met or exceeded the requirements of the THA and HealthSHARE independent evaluation.

For over 40 years, HealthSHARE has partnered with companies in the industry to bring Texas and Oklahoma the best available products and services. As a THA-endorsed company, CredenceHealth adds health care information technology solutions to the portfolio of endorsed company offerings. CredenceHealth's Web-based solutions leverage existing HIT investments in hospitals and provide immediate value in both quality and efficiency by translating clinical data into clinical intelligence. The value and functionality that the CredenceHealth suite provides enhances both the immediate and long-term quality initiatives of hospitals throughout the region.

"It is imperative, in today's market, that hospitals be able to actively monitor and measure the quality of the care that they give and be able to act upon the information that is captured within various systems effectively. CredenceHealth solutions provide that capability in a way that can easily be integrated into the operational routine within hospitals, resulting in improved care and reduced costs," said Jim Dixon, President and CEO of HealthSHARE.  

CredenceHealth began working in 2007 to develop and implement this system and today marks a major milestone in the life of the company.  "It's always special when two organizations with aligned missions work together toward a common goal. THA, through this endorsement, is taking innovative steps to improve the quality of care and reduce costs. The formation of this partnership will help to achieve those goals and to deliver tremendous capabilities to burdened health care providers," said Justin Lanning, President & CEO, CredenceHealth.

About Texas Hospital AssociationFounded in 1930, the Texas Hospital Association is the leadership organization and principal advocate for the state's hospitals and health care systems. Based in Austin, THA enhances its members' abilities to improve accessibility, quality and cost-effectiveness of health care for all Texans. One of the largest hospital associations in the country, THA represents more than 85 percent of the state's acute-care hospitals and health care systems, which employ some 355,000 health care professionals statewide. Learn more at www.tha.org.

About CredenceHealthCredenceHealth applies dynamic, evidence-based clinical research to real-time patient information (e.g. laboratory, radiology, medications, vital signs, etc.) to provide hospital clinicians across varying disciplines with actionable views, alerts, and notifications, resulting in major improvements, including: avoidable bed days, patient throughput, patient quality outcomes, avoidance of hospital acquired complications, and workflow efficiencies. CredenceHealth real-time clinical surveillance enables clinicians to return to care, allows hospitals to move to concurrent Core Measure compliance, and alerts clinicians to emerging complications within their patient population.  More at www.credencehealth.md.Media Contact:Silas DeaneDeane*Smith Media(615) 319-6007
'/>"/>

SOURCE CredenceHealth
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
2. Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
3. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
4. Mylan Declares Quarterly Preferred Stock Dividend
5. Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study
6. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
9. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
10. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
11. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):